- Navigating Your Midlife Crisis: Embracing New Possibilities
- City Raccoons Showing Signs of Domestication
- Mapping the Exposome: Science Broadens Focus to Environmental Disease Triggers
- One Week Less on Social Media Linked to Better Mental Health
- Your Brain Changes in Stages as You Age, Study Finds
- Some Suicide Victims Show No Typical Warning Signs, Study Finds
- ByHeart Formula Faces Lawsuits After Babies Sickened With Botulism
- Switch to Vegan Diet Could Cut Your Greenhouse Gas Emissions in Half
- Regular Bedtime Does Wonders for Blood Pressure
- Dining Alone Could Mean Worse Nutrition for Seniors
Dialysis Patients Have Weaker Response to COVID Vaccine: Study
A single dose of a COVID-19 vaccine isn’t enough to develop adequate antibodies in kidney dialysis patients, Canadian researchers report.
“We advise that the second dose of the [Pfizer] vaccine be administered to patients receiving hemodialysis at the recommended 3-week time interval and that rigorous SARS-CoV-2 infection prevention and control measures be continued in hemodialysis units until vaccine efficacy is known,” said researcher Dr. Rita Suri, a kidney specialist at the Research Institute of McGill University Health Center in Montreal.
Dialysis patients are especially vulnerable to COVID as they must visit a treatment center three times a week. Among these patients, between 20% and 30% of cases are fatal — 10 times higher than in the general population.
The study included 154 dialysis patients, 40 healthy volunteers and plasma from 16 dialysis patients who survived COVID.
After one dose of the Pfizer vaccine, antibodies could not be detected in 57% of dialysis patients, researchers found. Of those, four developed COVID after vaccination.
“Patients receiving hemodialysis who did not respond at 4 weeks remained non-responders at eight weeks, which is an argument against the possibility of a delayed response in these individuals,” the authors wrote.
Older patients and those on immunosuppressant drugs had even lower rates of producing antibodies, according to the study. In addition, younger patients who were not on the drugs had a significantly lower rate of antibody production than the healthy control group, researchers wrote.
How well dialysis patients respond to the second dose of vaccine is under study.
The findings were published May 12 in the Canadian Medical Association Journal.
More information
For more on COVID-19 vaccines, head to the U.S. Centers for Disease Control and Prevention.
SOURCE: Canadian Medical Association Journal, news release, May 12, 2021
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.
Related
-
Navigating Your Midlife Crisis: Embracing New PossibilitiesA midlife crisis can open doors to personal growth...
- December 4, 2025
-
Want A Happier Hospital? Hire More Nurses, Study SaysAdding even a few extra nurses can dramatically reduce...
- November 20, 2025
-
Plasma Treatment Shows Promise For Menopause Symptoms Among Breast Cancer SurvivorsPlasma infusions may help breast cancer survivors avoid genital...
- November 20, 2025
-
Self-Hypnosis Can Thwart Hot FlashesSelf-hypnosis might help some women in menopause find relief...
- November 14, 2025
